Redirecting to https://newsroom.astellas.us/2018-11-28-XOSPATA-R-gilteritinib-Approved-by-U-S-FDA-for-Adult-Patients-with-Relapsed-Refractory-Acute-Myeloid-Leukemia-AML-with-a-FLT3-Mutation...

Click here if your browser doesn't automatically take you to this page.